(Q34218091)

31 July 2017

TACE and other ADAM proteases as targets for drug discovery (English)

1 reference

31 July 2017

1 reference

M L. Moss

1

1 reference

31 July 2017

J M. White

series ordinal

2

1 reference

31 July 2017

M H. Lambert

series ordinal

3

1 reference

31 July 2017

R C. Andrews

series ordinal

4

1 reference

31 July 2017

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

6

1 reference

31 July 2017

8

1 reference

31 July 2017

417-426

1 reference

ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

ADAMs: focus on the protease domain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The ADAM gene family: surface proteins with adhesion and protease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Sequence-specific interaction between the disintegrin domain of mouse ADAM 2 (fertilin beta) and murine eggs. Role of the alpha(6) integrin subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Sequence-specific interaction between the disintegrin domain of mouse ADAM 3 and murine eggs: role of beta1 integrin-associated proteins CD9, CD81, and CD98.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

ADAMs in fertilization and development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Evidence for an interaction of the metalloprotease‒disintegrin tumour necrosis factor α convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease‒disintegrin MDC9 with a novel MAD2-related protein, MAD2β

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Trafficking of human ADAM 12-L: retention in the trans-Golgi network

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Purification of ADAM 10 from bovine spleen as a TNFalpha convertase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

An essential role for ectodomain shedding in mammalian development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Strain-dependent epithelial defects in mice lacking the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Localization of ADAM10 and Notch receptors in bone

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Regulated cleavage of a contact-mediated axon repellent

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Cleavage of amyloid beta peptide during constitutive processing of its precursor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Regulation of APP cleavage by alpha-, beta- and gamma-secretases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A common enzyme connects notch signaling and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Processing of the notch ligand delta by the metalloprotease Kuzbanian

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A metalloprotease-disintegrin participating in myoblast fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Human ADAM 12 (meltrin alpha) is an active metalloprotease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Novel aspects of the insulin-like growth factor binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

2 angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Structures of adamalysin II with peptidic inhibitors. Implications for the design of tumor necrosis factor alpha convertase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF alpha processing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Preclinical and clinical studies of MMP inhibitors in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Regulation of Human ADAM 12 Protease by the Prodomain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

Purification and cloning of amyloid precursor protein beta-secretase from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901738-X

7 January 2021

10.1016/S1359-6446(01)01738-X

Identifiers

DOI

1 reference

31 July 2017

1 reference